• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis.

作者信息

Padoan Roberto, Chieco Bianchi Fulvia, Marchi Maria Rita, Cazzador Diego, Felicetti Mara, Emanuelli Enzo, Vianello Andrea, Nicolai Piero, Doria Andrea, Schiavon Franco

机构信息

Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy.

Respiratory Pathophysiology Division, Department of Cardio-Thoracic-Vascular Sciences, University of Padova, Padova, Italy.

出版信息

J Allergy Clin Immunol Pract. 2020 Oct;8(9):3225-3227.e2. doi: 10.1016/j.jaip.2020.05.033. Epub 2020 Jun 4.

DOI:10.1016/j.jaip.2020.05.033
PMID:32505716
Abstract
摘要

相似文献

1
Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis.贝那利珠单抗作为嗜酸性肉芽肿性多血管炎严重哮喘的糖皮质激素节省治疗选择。
J Allergy Clin Immunol Pract. 2020 Oct;8(9):3225-3227.e2. doi: 10.1016/j.jaip.2020.05.033. Epub 2020 Jun 4.
2
Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab.在用贝那利珠单抗治疗严重嗜酸性粒细胞性哮喘期间，嗜酸性肉芽肿性多血管炎的病情进展
J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2448-2449. doi: 10.1016/j.jaip.2020.04.006. Epub 2020 Apr 15.
3
Benralizumab in eosinophilic granulomatosis with polyangiitis.贝那利珠单抗治疗嗜酸性肉芽肿性多血管炎
Med Clin (Barc). 2022 May 13;158(9):441-442. doi: 10.1016/j.medcli.2021.07.017. Epub 2021 Oct 30.
4
Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis.贝那鲁肽对伴有嗜酸性粒细胞肉芽肿伴多血管炎的严重嗜酸性粒细胞性哮喘加重的快速作用。
BMC Pulm Med. 2021 Jan 21;21(1):35. doi: 10.1186/s12890-021-01397-7.
5
[Benralizumab in cases of eosinophilic granulomatosis with polyangiitis].[贝那利珠单抗用于嗜酸性肉芽肿性多血管炎病例]
Rev Mal Respir. 2022 Sep;39(7):621-625. doi: 10.1016/j.rmr.2022.06.004. Epub 2022 Jul 29.
6
Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma.一名接受白细胞介素-5通路抑制剂治疗严重哮喘的患者发生了嗜酸性肉芽肿性多血管炎。
Rheumatology (Oxford). 2021 Feb 1;60(2):e59-e60. doi: 10.1093/rheumatology/keaa572.
7
Eosinophilic granulomatosis with polyangiitis successfully treated with benralizumab.使用贝那利珠单抗成功治疗嗜酸性肉芽肿性多血管炎。
Ann Allergy Asthma Immunol. 2020 Aug;125(2):228-230. doi: 10.1016/j.anai.2020.05.002. Epub 2020 May 11.
8
Benralizumab as a Potential Adjunctive Therapy in Eosinophilic Granulomatosis With Polyangiitis.贝那利珠单抗作为嗜酸性肉芽肿性多血管炎的潜在辅助治疗药物。
J Clin Rheumatol. 2021 Dec 1;27(8S):S401-S402. doi: 10.1097/RHU.0000000000001419.
9
Churg-Strauss syndrome.变应性肉芽肿性血管炎
Semin Respir Crit Care Med. 2006 Apr;27(2):148-57. doi: 10.1055/s-2006-939518.
10
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis.贝那鲁肽作为嗜酸性肉芽肿伴多血管炎的一种类固醇节约治疗选择。
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1186-1193.e1. doi: 10.1016/j.jaip.2020.09.054. Epub 2020 Oct 14.

引用本文的文献

1
Anti-IL5/IL-5 receptor therapies for eosinophilic granulomatosis with polyangiitis: an updated Systematic Review.抗白细胞介素5/白细胞介素-5受体疗法治疗嗜酸性肉芽肿性多血管炎：最新系统评价
Front Immunol. 2025 Jul 22;16:1587158. doi: 10.3389/fimmu.2025.1587158. eCollection 2025.
2
Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis.贝那利珠单抗可减少重度哮喘合并嗜酸性肉芽肿性多血管炎患者的呼吸道急性加重次数并降低口服糖皮质激素剂量。
J Asthma Allergy. 2024 Jun 6;17:557-572. doi: 10.2147/JAA.S461800. eCollection 2024.
3
Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis.
美泊利单抗和贝那利单抗用于治疗重度哮喘且有嗜酸性肉芽肿性多血管炎病史的患者。
Front Med (Lausanne). 2024 Mar 22;11:1341310. doi: 10.3389/fmed.2024.1341310. eCollection 2024.
4
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.美泊利单抗和贝那利珠单抗治疗重度嗜酸性粒细胞性哮喘及嗜酸性肉芽肿性多血管炎的“超级应答者”的真实世界特征
ERJ Open Res. 2023 Oct 30;9(5). doi: 10.1183/23120541.00419-2023. eCollection 2023 Sep.
5
Anti-IL5 Monoclonal Antibodies Reduce Asthma Exacerbations and Corticosteroids Dose in Three Eosinophilic Granulomatosis with Polyangiitis Case Reports.抗白细胞介素-5单克隆抗体在三例嗜酸性肉芽肿性多血管炎病例报告中减少哮喘发作及皮质类固醇剂量
Mediterr J Rheumatol. 2023 Jun 30;34(2):238-244. doi: 10.31138/mjr.34.2.238. eCollection 2023 Jun.
6
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.抗白细胞介素-5/受体α 生物制剂治疗嗜酸性肉芽肿伴多血管炎的疗效和安全性：一项为期两年的多中心观察性研究。
Front Immunol. 2023 Jun 30;14:1204444. doi: 10.3389/fimmu.2023.1204444. eCollection 2023.
7
Characteristics of severe asthma patients on biologics: a real-life European registry study.接受生物制剂治疗的重度哮喘患者的特征：一项欧洲真实世界注册研究
ERJ Open Res. 2023 May 2;9(3). doi: 10.1183/23120541.00586-2022. eCollection 2023 Jul.
8
The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review.抗嗜酸性粒细胞治疗在嗜酸性肉芽肿性多血管炎中的作用：系统评价。
Rheumatol Int. 2023 Jul;43(7):1245-1252. doi: 10.1007/s00296-023-05326-1. Epub 2023 Apr 21.
9
Editorial: Pathophysiological and clinical advances in asthmatic inflammation from the nasopharynx to the peripheral airway in the respiratory tract systems.社论：呼吸道系统中从鼻咽到外周气道的哮喘炎症的病理生理与临床进展
Front Pharmacol. 2023 Jan 16;14:1037610. doi: 10.3389/fphar.2023.1037610. eCollection 2023.
10
Long-term Safety and Efficacy of Benralizumab for Eosinophilic Granulomatosis with Polyangiitis Complicated with Severe Neuropathy.贝那鲁肽治疗伴有严重神经病变的嗜酸性肉芽肿伴多血管炎的长期安全性和疗效。
Intern Med. 2023 May 15;62(10):1553-1556. doi: 10.2169/internalmedicine.0613-22. Epub 2022 Sep 28.